Global Iron Deficiency Anemia Therapy Industry Outlook 2021: Overview, Opportunities, Key Companies and Forecast to 2027
Report Code: KNJ918323 No. of Pages: 109 Category: Pharmaceuticals and Healthcare
Publisher: Date of Publish:
Publisher: Date of Publish:
Executive Summary
According to GRD Survey data, the global Iron Deficiency Anemia Therapy market was valued at million US$ in 2020 and is expected to million US$ by the end of 2027, growing at a CAGR of % in the forecast period 2021 and 2027.
This report studies the Iron Deficiency Anemia Therapy market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (Million USD) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
Geographically, this report is segmented into several key regions, with revenue, market share and growth Rate of Iron Deficiency Anemia Therapy in these regions, from 2016 to 2027, covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)
Market Snapshot, By Product Type
Oral Iron Therapy
Parenteral Iron Therapy
Red Blood Cell Transfusion
Other
Market Snapshot, By Application
Hospitals
Clinics
Home Healthcare
Other
Market Snapshot, By Region:
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
South Africa
Israel
Turkey
Saudi Arabia
Main Market Players Analyzed in this report, including:
Vifor Pharma
Teoxane
Sinclair Pharma
Pieris
Pharmacosmos AS
Luitpold Pharmaceuticals
Keryx Biopharmaceuticals
Johnson & Johnson
Integra Lifesciences
Galderma Pharma
AMAG Pharmaceuticals
Allergan
Akebia Therapeutics
The study objectives of this report are:
To study and analyze the global Iron Deficiency Anemia Therapy market size (Million USD) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.
To understand industry structure of Iron Deficiency Anemia Therapy market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To identify the key global Iron Deficiency Anemia Therapy manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Iron Deficiency Anemia Therapy market with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Iron Deficiency Anemia Therapy submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Iron Deficiency Anemia Therapy are as follows:
History Year: 2016-2020
Base Year: 2020
Estimated Year: 2021
Forecast Year 2021 to 2027
This report includes the estimation of market size from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders Considered in the study:
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries
Table of Contents
1 Market Definition & Scope
1.1 Definition & Scope
1.2 Iron Deficiency Anemia Therapy Product Specifications
1.3 Main Events (Entry, M&A, Exit, Technology and Capital Activity)
1.4 Global Iron Deficiency Anemia Therapy Market Performance and Outlook
2 Market Development Performance under COVID-19
2.1 Influencing Factors of Industry Development in the Next Five Years
2.1.1 Drivers
2.1.2 Restraints
2.1.3 Opportunities
2.2 Porter’s Five Forces Analysis
2.3 Comparison of Alternatives and Iron Deficiency Anemia Therapy
3 3 Industrial Lift Cycle and Main Buyers Analysis
3.1 Industry Life Cycle Analysis
3.2 Key Buying Industries/Consumers
3.2.1 Major Buyers in Hospitals
3.2.2 Major Buyers in Clinics
4 Market Segment: by Type
4.1 Iron Deficiency Anemia Therapy Type Introduction
4.1.1 Oral Iron Therapy
4.1.2 Parenteral Iron Therapy
4.1.3 Red Blood Cell Transfusion
4.1.4 Other
4.2 Global Iron Deficiency Anemia Therapy Revenue by Type 2016-2021
5 Market Segment: by Application
5.1 Iron Deficiency Anemia Therapy Type Introduction
5.1.1 Hospitals
5.1.2 Clinics
5.1.3 Home Healthcare
5.1.3 Other
5.2 Global Iron Deficiency Anemia Therapy Revenue by Application 2016-2021
6 Marke Segment: by Region
6.1 Global Iron Deficiency Anemia Therapy Market by Region
6.2 North America Iron Deficiency Anemia Therapy Market 2016-2021
6.3 Europe Iron Deficiency Anemia Therapy Market 2016-2021
6.4 Asia Pacific Iron Deficiency Anemia Therapy Market 2016-2021
6.5 South America Iron Deficiency Anemia Therapy Market 2016-2021
6.6 Middle East and Africa Iron Deficiency Anemia Therapy Market 2016-2021
7 North America
7.1 North America Iron Deficiency Anemia Therapy Market by Country 2016-2021
7.2 United States
7.3 Canada
7.4 Mexico
8 Europe
8.1 Europe Iron Deficiency Anemia Therapy Market by Country 2016-2021
8.2 Germany
8.3 France
8.4 UK
8.5 Italy
8.6 Russia
8.7 Spain
9 Asia Pacific
9.1 Asia Pacific Iron Deficiency Anemia Therapy Market by Country 2016-2021
9.2 China
9.3 Japan
9.4 Korea
9.5 Southeast Asia
9.6 India
9.7 Australia
10 South America
10.1 South America Iron Deficiency Anemia Therapy Market by Country 2016-2021
10.2 Brazil
10.3 Argentina
10.4 Colombia
11 Middle East and Africa
11.1 Middle East and Africa Iron Deficiency Anemia Therapy Market by Country 2016-2021
11.2 Turkey
11.3 Saudi Arabia
11.4 South Africa
12 Key Participants Company Information
12.1 Vifor Pharma
12.1.1 Vifor Pharma
Company Information
12.1.2 Vifor Pharma
Iron Deficiency Anemia Therapy Product Portfolio, Specification and Application
12.1.3 Vifor Pharma
Iron Deficiency Anemia Therapy Revenue and Gross Margin (2019-2021)
12.1.4 Vifor Pharma
Key Development
12.2 Teoxane
12.2.1 Teoxane
Company Information
12.2.2 Teoxane
Iron Deficiency Anemia Therapy Product Portfolio, Specification and Application
12.2.3 Teoxane
Iron Deficiency Anemia Therapy Revenue and Gross Margin (2019-2021)
12.2.4 Teoxane
Key Development
12.3 Sinclair Pharma
12.3.1 Sinclair Pharma
Company Information
12.3.2 Sinclair Pharma
Iron Deficiency Anemia Therapy Product Portfolio, Specification and Application
12.3.3 Sinclair Pharma
Iron Deficiency Anemia Therapy Revenue and Gross Margin (2019-2021)
12.3.4 Sinclair Pharma
Key Development
12.4 Pieris
12.4.1 Pieris
Company Information
12.4.2 Pieris
Iron Deficiency Anemia Therapy Product Portfolio, Specification and Application
12.4.3 Pieris
Iron Deficiency Anemia Therapy Revenue and Gross Margin (2019-2021)
12.4.4 Pieris
Key Development
12.5 Pharmacosmos AS
12.5.1 Pharmacosmos AS
Company Information
12.5.2 Pharmacosmos AS
Iron Deficiency Anemia Therapy Product Portfolio, Specification and Application
12.5.3 Pharmacosmos AS
Iron Deficiency Anemia Therapy Revenue and Gross Margin (2019-2021)
12.5.4 Pharmacosmos AS
Key Development
12.6 Luitpold Pharmaceuticals
12.6.1 Luitpold Pharmaceuticals
Company Information
12.6.2 Luitpold Pharmaceuticals
Iron Deficiency Anemia Therapy Product Portfolio, Specification and Application
12.6.3 Luitpold Pharmaceuticals
Iron Deficiency Anemia Therapy Revenue and Gross Margin (2019-2021)
12.6.4 Luitpold Pharmaceuticals
Key Development
12.7 Keryx Biopharmaceuticals
12.7.1 Keryx Biopharmaceuticals
Company Information
12.7.2 Keryx Biopharmaceuticals
Iron Deficiency Anemia Therapy Product Portfolio, Specification and Application
12.7.3 Keryx Biopharmaceuticals
Iron Deficiency Anemia Therapy Revenue and Gross Margin (2019-2021)
12.7.4 Luitpold Pharmaceuticals
Key Development
12.9 Integra Lifesciences
12.9.1 Integra Lifesciences
Company Information
12.9.2 Integra Lifesciences
Iron Deficiency Anemia Therapy Product Portfolio, Specification and Application
12.9.3 Integra Lifesciences
Iron Deficiency Anemia Therapy Revenue and Gross Margin (2019-2021)
12.9.4 Integra Lifesciences
Key Development
12.8 Johnson & Johnson
12.8.1 Johnson & Johnson
Company Information
12.8.2 Johnson & Johnson
Iron Deficiency Anemia Therapy Product Portfolio, Specification and Application
12.8.3 Johnson & Johnson
Iron Deficiency Anemia Therapy Revenue and Gross Margin (2019-2021)
12.8.4 Johnson & Johnson
Key Development
12.11 AMAG Pharmaceuticals
12.11.1 AMAG Pharmaceuticals
Company Information
12.11.2 AMAG Pharmaceuticals
Iron Deficiency Anemia Therapy Product Portfolio, Specification and Application
12.11.3 AMAG Pharmaceuticals
Iron Deficiency Anemia Therapy Revenue and Gross Margin (2019-2021)
12.11.4 AMAG Pharmaceuticals
Key Development
12.12 Allergan
12.12.1 Allergan
Company Information
12.12.2 Allergan
Iron Deficiency Anemia Therapy Product Portfolio, Specification and Application
12.12.3 Allergan
Iron Deficiency Anemia Therapy Revenue and Gross Margin (2019-2021)
12.12.4 Allergan
Key Development
12.13 Akebia Therapeutics
12.13.1 Akebia Therapeutics
Company Information
12.13.2 Akebia Therapeutics
Iron Deficiency Anemia Therapy Product Portfolio, Specification and Application
12.13.3 Akebia Therapeutics
Iron Deficiency Anemia Therapy Revenue and Gross Margin (2019-2021)
12.13.4 Akebia Therapeutics
Key Development
13 Global Iron Deficiency Anemia Therapy Market Forecast by Region by Type and by Application
13.1 Global Iron Deficiency Anemia Therapy Revenue Forecast 2022-2027
13.2 Global Iron Deficiency Anemia Therapy Forecast by Regions
13.3 Global Iron Deficiency Anemia Therapy Forecast by Type
13.4 Global Iron Deficiency Anemia Therapy Forecast by Application
14 Analyst Views and Conclusions
15 Methodology and Data Source
15.1 Methodology
15.2 Research Data Source
15.2.1 Secondary Data
15.2.2 Primary Data
15.2.3 Market Size Estimation
15.3 Legal Disclaimer
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com